申请人:HOPE CITY
公开号:WO2018232274A1
公开(公告)日:2018-12-20
Described herein are methods for treating T-cell lymphoma in a subject in need thereof, comprising administering to the subject in need thereof, an ETP compound. Also described herein are pharmaceutical compositions and compositions for use that include such ETP compound.
本文描述了治疗需要的T细胞淋巴瘤的方法,包括向需要的受试者施用ETP化合物。本文还描述了包含这种ETP化合物的药物组合物和用途组合物。